We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Honeybee Propolis Extract Impedes Prostate Cancer Cell Growth

By LabMedica International staff writers
Posted on 14 May 2012
Cancer researchers have discovered the molecular mechanism that utilizes the honeybee propolis component caffeic acid phenethyl ester (CAPE) to arrest the growth of prostate cancer cells in culture and in mouse xenografts.

CAPE is a bioactive component derived from honeybee hive propolis. More...
It has been shown to have antimitogenic, anticarcinogenic, and other beneficial medicinal properties. Many of its effects have been shown to be mediated through its inhibition of NF-kappaB signaling pathways. Notably, CAPE down-regulates the mdr-1 gene, considered responsible for the resistance of cancer cells to chemotherapeutic agents.

In the current study investigator at the University of Chicago (IL, USA) employed a systematic approach to uncover the long- and short- term effects of CAPE on the signaling networks in human prostate cancer cells.

They reported in the May 1, 2012, issue of the journal Cancer Prevention Research that dosages of CAPE dependently suppressed the proliferation in culture of the LNCaP, DU-145, and PC-3 lines of human prostate cancer cells. Furthermore, administration of CAPE significantly inhibited growth of LNCaP tumor xenografts in nude mice.

Working with LNCaP cells as a model system, the investigators examined the effect of CAPE on gene expression, protein signaling, and transcriptional regulatory networks using a novel series of micro-Western and PCR arrays. They found that CAPE acted through inhibition of Akt-related protein signaling networks. Akt, also known as protein kinase B (PKB), is a serine/threonine-specific protein kinase that plays a key role in multiple cellular processes such as glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration. Overexpression of Akt-1 or c-Myc (v-myc myelocytomatosis viral oncogene homolog), a downstream target of Akt signaling, significantly blocked the antiproliferative effects of CAPE.

“If you feed CAPE to mice daily, their tumors will stop growing. After several weeks, if you stop the treatment, the tumors will begin to grow again at their original pace,” said senior author Dr. Richard B. Jones, assistant professor of genomics and systems biology at the University of Chicago. “So it does not kill the cancer, but it basically will indefinitely stop prostate cancer proliferation.”

“It appears that CAPE basically stops the ability of prostate cancer cells to sense that there is nutrition available. They stop all of the molecular signatures that would suggest that nutrition exists, and the cells no longer have that proliferative response to nutrition,” said Dr. Jones. “A typical problem in bringing some of these herbal remedies into the clinic is that nobody knows how they act, nobody knows the mechanism, and therefore researchers are typically very hesitant to add them to any pharmaceutical treatment strategy. Now we will actually be able to systematically demonstrate the parts of cell physiology that are affected by these compounds.”

Related Links:

University of Chicago



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PSA Assay
CanAg PSA EIA
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.